Largest Diagnostics & Research Companies by Market Cap
The Diagnostics & Research sector has 167 publicly listed stocks with a combined market cap of $892.92 Billion. Thermo Fisher Scientific Inc leads the sector with a market cap of $176.29 Billion. This ranking covers all Diagnostics & Research stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$892.92 Billion
Companies Listed
167
Largest Company
Thermo Fisher Scientific …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Thermo Fisher Scientific Inc
NYSE:TMO |
$176.29 Billion | $176.29 Billion | USA | $469.21 | -2.04% | +0.54% | 43.80 Million |
| 2 |
Danaher Corporation
NYSE:DHR |
$123.72 Billion | $123.72 Billion | USA | $175.15 | -2.12% | -1.92% | 104.35 Million |
| 3 |
IDEXX Laboratories Inc
NASDAQ:IDXX |
$45.31 Billion | $45.31 Billion | USA | $567.46 | +1.19% | +1.16% | 12.88 Million |
| 4 |
LONZA GROUP UNSP.ADR 1/10
F:LO3A |
$41.04 Billion | €35.10 Billion | Germany | €54.50 | +0.00% | -3.54% | 230.00 |
| 5 |
WuXi AppTec Co Ltd
SHG:603259 |
$39.65 Billion | CN¥270.95 Billion | China | CN¥109.55 | -1.47% | +10.38% | 1.08 Billion |
| 6 |
Lonza Group AG
SW:LONN |
$35.36 Billion | CHF27.96 Billion | Switzerland | CHF479.20 | +1.10% | -5.71% | 4.23 Million |
| 7 |
Agilent Technologies Inc
NYSE:A |
$32.42 Billion | $32.42 Billion | USA | $114.52 | -0.89% | +0.09% | 36.85 Million |
| 8 |
Waters Corporation
NYSE:WAT |
$30.13 Billion | $30.13 Billion | USA | $307.12 | -0.68% | -1.31% | 18.59 Million |
| 9 |
Natera Inc
NASDAQ:NTRA |
$28.77 Billion | $28.77 Billion | USA | $207.28 | +0.54% | +3.05% | 30.79 Million |
| 10 |
IQVIA Holdings Inc
NYSE:IQV |
$26.76 Billion | $26.76 Billion | USA | $157.77 | -0.38% | -1.81% | 29.29 Million |
| 11 |
Mettler-Toledo International Inc
NYSE:MTD |
$25.66 Billion | $25.66 Billion | USA | $1267.07 | -0.75% | +0.21% | 2.66 Million |
| 12 |
Labcorp Holdings Inc.
MX:LH |
$22.45 Billion | MX$390.06 Billion | Mexico | MX$4705.14 | +0.00% | -4.17% | 2.11K |
| 13 |
Quest Diagnostics Incorporated
NYSE:DGX |
$21.24 Billion | $21.24 Billion | USA | $192.67 | -0.79% | -3.44% | 24.95 Million |
| 14 |
Laboratory Corporation of America Holdings
NYSE:LH |
$21.21 Billion | $21.21 Billion | USA | $255.84 | -0.37% | -3.43% | 13.72 Million |
| 15 |
EXACT Sciences Corporation
NASDAQ:EXAS |
$19.80 Billion | $19.80 Billion | USA | $1819.87 | +0.25% | -2.61% | 37.42 Million |
| 16 |
Illumina Inc
NASDAQ:ILMN |
$18.34 Billion | $18.34 Billion | USA | $135.78 | +7.13% | +8.24% | 34.53 Million |
| 17 |
Medpace Holdings Inc
NASDAQ:MEDP |
$11.92 Billion | $11.92 Billion | USA | $417.54 | -0.27% | +6.13% | 10.77 Million |
| 18 |
Eurofins Scientific SE
PA:ERF |
$11.53 Billion | €9.87 Billion | France | €59.02 | +2.57% | -5.78% | 8.40 Million |
| 19 |
Eurofins Scientific SE
F:ESF0 |
$11.18 Billion | €9.56 Billion | Germany | €59.16 | +0.92% | -4.05% | 2.73K |
| 20 |
Guardant Health Inc
NASDAQ:GH |
$11.02 Billion | $11.02 Billion | USA | $87.60 | +0.60% | -0.31% | 50.99 Million |
| 21 |
Biomerieux SA
PA:BIM |
$9.90 Billion | €8.47 Billion | France | €71.70 | +5.05% | -19.21% | 4.73 Million |
| 22 |
Revvity Inc.
NYSE:RVTY |
$9.69 Billion | $9.69 Billion | USA | $86.68 | +0.07% | -0.54% | 22.14 Million |
| 23 |
WuXi AppTec Co. Ltd
F:WX8 |
$8.77 Billion | €7.50 Billion | Germany | €14.69 | -0.57% | +13.49% | 754.00 |
| 24 |
ICON Public Limited Company
F:IJF |
$8.69 Billion | €7.43 Billion | Germany | €97.36 | +12.89% | +0.47% | 120.00 |
| 25 |
Charles River Laboratories
NYSE:CRL |
$7.94 Billion | $7.94 Billion | USA | $165.78 | -0.71% | -1.17% | 16.07 Million |
| 26 |
ICON PLC
NASDAQ:ICLR |
$7.23 Billion | $7.23 Billion | USA | $112.85 | -4.63% | +6.12% | 30.91 Million |
| 27 |
Qiagen NV
NYSE:QGEN |
$7.06 Billion | $7.06 Billion | USA | $34.25 | -0.95% | -9.80% | 41.83 Million |
| 28 |
Sonic Healthcare Ltd
AU:SHL |
$6.98 Billion | AU$9.86 Billion | Australia | AU$19.96 | +0.96% | -1.14% | 39.19 Million |
| 29 |
Hangzhou Tigermed Consulting
SHE:300347 |
$5.96 Billion | CN¥40.73 Billion | China | CN¥55.20 | -2.09% | -3.82% | 320.49 Million |
| 30 |
RadNet Inc
NASDAQ:RDNT |
$4.40 Billion | $4.40 Billion | USA | $56.85 | +0.53% | +0.73% | 17.98 Million |
| 31 |
Sotera Health Co
NASDAQ:SHC |
$4.33 Billion | $4.33 Billion | USA | $15.50 | -0.39% | +1.11% | 64.25 Million |
| 32 |
Joinn Laboratories(China)Co
SHG:603127 |
$3.59 Billion | CN¥24.50 Billion | China | CN¥38.87 | +0.60% | +3.05% | 944.34 Million |
| 33 |
BillionToOne, Inc. Class A Common Stock
NASDAQ:BLLN |
$3.21 Billion | $3.21 Billion | USA | $77.49 | +3.25% | -7.67% | 9.43 Million |
| 34 |
Twist Bioscience Corp
NASDAQ:TWST |
$3.01 Billion | $3.01 Billion | USA | $60.40 | +3.34% | +2.63% | 31.54 Million |
| 35 |
Veracyte Inc
NASDAQ:VCYT |
$2.62 Billion | $2.62 Billion | USA | $33.09 | +0.52% | -0.18% | 16.87 Million |
| 36 |
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB |
$2.47 Billion | Rs228.29 Billion | India | Rs1367.20 | -2.19% | -6.30% | 7.91 Million |
| 37 |
BGI Genomics Co Ltd
SHE:300676 |
$2.44 Billion | CN¥16.71 Billion | China | CN¥39.94 | -0.89% | +0.43% | 122.07 Million |
| 38 |
Neogen Corporation
NASDAQ:NEOG |
$2.07 Billion | $2.07 Billion | USA | $9.53 | +1.38% | +1.93% | 63.55 Million |
| 39 |
Syngene International Limited
NSE:SYNGENE |
$2.03 Billion | Rs187.86 Billion | India | Rs467.65 | +8.21% | +7.27% | 88.84 Million |
| 40 |
GeneDx Holdings Corp.
NASDAQ:WGS |
$1.89 Billion | $1.89 Billion | USA | $65.38 | +3.96% | -1.30% | 14.40 Million |
| 41 |
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
$1.85 Billion | CN¥12.65 Billion | China | CN¥27.30 | -0.80% | -5.24% | 120.95 Million |
| 42 |
GRAIL, LLC
NASDAQ:GRAL |
$1.79 Billion | $1.79 Billion | USA | $54.06 | -0.77% | +6.73% | 17.58 Million |
| 43 |
Zhejiang DiAn Diagnostics Co
SHE:300244 |
$1.77 Billion | CN¥12.09 Billion | China | CN¥19.34 | -0.77% | -1.73% | 517.33 Million |
| 44 |
Fleury S.A.
SA:FLRY3 |
$1.72 Billion | R$8.78 Billion | Brazil | R$16.08 | +0.31% | -2.55% | 62.45 Million |
| 45 |
Vimian Group AB
ST:VIMIAN |
$1.70 Billion | Skr15.83 Billion | Sweden | Skr30.10 | -0.99% | +0.84% | 5.94 Million |
| 46 |
Vijaya Diagnostic Centre Limited
NSE:VIJAYA |
$1.26 Billion | Rs116.23 Billion | India | Rs1129.60 | +1.40% | +8.53% | 3.84 Million |
| 47 |
Shanghai Runda Med Tech Co
SHG:603108 |
$1.19 Billion | CN¥8.11 Billion | China | CN¥13.43 | -0.89% | -3.31% | 333.87 Million |
| 48 |
Amoy Diagnostics Co Ltd
SHE:300685 |
$1.16 Billion | CN¥7.91 Billion | China | CN¥20.21 | -1.46% | -10.38% | 267.16 Million |
| 49 |
Beijing Strong Biotechnologies Inc
SHE:300406 |
$1.09 Billion | CN¥7.45 Billion | China | CN¥12.70 | +2.58% | +6.90% | 111.23 Million |
| 50 |
NeoGenomics Inc
NASDAQ:NEO |
$1.03 Billion | $1.03 Billion | USA | $9.44 | +1.94% | +19.34% | 59.76 Million |
| 51 |
CareDx Inc
NASDAQ:CDNA |
$1.00 Billion | $1.00 Billion | USA | $21.50 | +3.32% | +7.18% | 18.46 Million |
| 52 |
Maccura Biotechnology Co Ltd
SHE:300463 |
$928.17 Million | CN¥6.34 Billion | China | CN¥10.49 | -0.94% | -1.22% | 134.28 Million |
| 53 |
Cowealth Medical China Co.Ltd.
SHG:603122 |
$876.63 Million | CN¥5.99 Billion | China | CN¥15.05 | -1.31% | -5.46% | 1.13 Billion |
| 54 |
Opko Health Inc
NASDAQ:OPK |
$844.47 Million | $844.47 Million | USA | $1.10 | -2.22% | -9.84% | 55.50 Million |
| 55 |
Clinica Baviera
MC:CBAV |
$842.36 Million | €720.51 Million | Spain | €55.80 | +3.33% | +4.89% | 84.81K |
| 56 |
Diagnósticos da América S.A
SA:DASA3 |
$828.87 Million | R$4.22 Billion | Brazil | R$3.38 | +13.80% | +7.64% | 49.15 Million |
| 57 |
Castle Biosciences Inc
NASDAQ:CSTL |
$724.17 Million | $724.17 Million | USA | $24.81 | +1.31% | +4.73% | 6.82 Million |
| 58 |
Thyrocare Technologies Limited
NSE:THYROCARE |
$689.03 Million | Rs63.71 Billion | India | Rs400.30 | -1.00% | +1.19% | 5.71 Million |
| 59 |
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
$678.46 Million | CN¥4.64 Billion | China | CN¥21.26 | +0.95% | -3.80% | 506.73 Million |
| 60 |
HANGZHOU TIGERMED CO. H 1
F:5HZ1 |
$618.97 Million | €529.44 Million | Germany | €4.30 | +1.42% | -4.87% | 98.00 |
| 61 |
SMO ClinPlus Co. Ltd.
SHE:301257 |
$605.79 Million | CN¥4.14 Billion | China | CN¥52.40 | -3.00% | -8.38% | 57.21 Million |
| 62 |
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060 |
$605.42 Million | CN¥4.14 Billion | China | CN¥10.33 | -1.81% | +6.71% | 165.10 Million |
| 63 |
Integral Diagnostics Ltd
AU:IDX |
$585.79 Million | AU$827.90 Million | Australia | AU$2.22 | -0.45% | +0.91% | 17.79 Million |
| 64 |
Guangdong Hybribio Biotech Co Ltd
SHE:300639 |
$573.30 Million | CN¥3.92 Billion | China | CN¥6.06 | -1.14% | -5.02% | 795.69 Million |
| 65 |
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439 |
$567.44 Million | CN¥3.88 Billion | China | CN¥10.09 | +0.00% | +3.28% | 105.59 Million |
| 66 |
Berry Genomics Co Ltd
SHE:000710 |
$516.80 Million | CN¥3.53 Billion | China | CN¥9.99 | +0.71% | +0.20% | 189.66 Million |
| 67 |
Personalis Inc
NASDAQ:PSNL |
$513.29 Million | $513.29 Million | USA | $5.78 | +4.71% | -2.03% | 42.74 Million |
| 68 |
Lumibird SA
PA:LBIRD |
$513.10 Million | €438.88 Million | France | €21.50 | +2.87% | -13.13% | 937.14K |
| 69 |
Myriad Genetics Inc
NASDAQ:MYGN |
$446.03 Million | $446.03 Million | USA | $4.80 | +1.05% | +0.21% | 24.50 Million |
| 70 |
Chemclin Diagnostics Co. Ltd. A
SHG:688468 |
$439.62 Million | CN¥3.00 Billion | China | CN¥7.49 | +1.08% | +3.03% | 74.87 Million |
| 71 |
Fulgent Genetics Inc
NASDAQ:FLGT |
$436.79 Million | $436.79 Million | USA | $14.13 | -6.98% | -11.85% | 11.32 Million |
| 72 |
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
$355.44 Million | CN¥2.43 Billion | China | CN¥60.62 | -1.70% | +7.71% | 17.33 Million |
| 73 |
Integrated Diagnostics Holdings PLC
LSE:IDHC |
$325.54 Million | $325.54 Million | UK | $0.56 | +0.00% | -9.97% | 2.78 Million |
| 74 |
INTERGRATED DIA.H DL 025
F:8I8 |
$315.01 Million | €269.45 Million | Germany | €0.48 | +0.85% | -0.83% | 150.00 |
| 75 |
Voxel S.A.
WAR:VOX |
$288.76 Million | zł1.05 Billion | Poland | zł99.90 | -0.89% | -1.67% | 330.47K |
| 76 |
Spectral Med Inc
TO:EDT |
$284.46 Million | CA$393.23 Million | Canada | CA$1.36 | +0.74% | -0.73% | 940.98K |
| 77 |
Metropolis Healthcare Limited
NSE:METROPOLIS |
$267.10 Million | Rs24.70 Billion | India | Rs476.50 | -0.48% | -0.03% | 7.04 Million |
| 78 |
Prenetics Global Ltd
NASDAQ:PRE |
$259.51 Million | $259.51 Million | USA | $17.02 | +1.86% | -2.74% | 3.74 Million |
| 79 |
Australian Clinical Labs Ltd
AU:ACL |
$256.90 Million | AU$363.07 Million | Australia | AU$1.92 | +1.59% | -2.04% | 19.36 Million |
| 80 |
Healius Ltd
AU:HLS |
$254.32 Million | AU$359.44 Million | Australia | AU$0.50 | -1.98% | -8.33% | 83.57 Million |
| 81 |
Green Cross Lab Cell Corporation
KQ:144510 |
$241.86 Million | ₩356.89 Billion | Korea | ₩23750.00 | -2.66% | -5.00% | 822.59K |
| 82 |
Vimta Labs Limited
NSE:VIMTALABS |
$220.67 Million | Rs20.40 Billion | India | Rs457.15 | +1.46% | -4.42% | 4.35 Million |
| 83 |
Krsnaa Diagnostics Limited
NSE:KRSNAA |
$206.54 Million | Rs19.10 Billion | India | Rs588.75 | +1.34% | -2.61% | 1.33 Million |
| 84 |
Monash Ivf Group Ltd
AU:MVF |
$202.63 Million | AU$286.38 Million | Australia | AU$0.74 | +0.68% | -1.34% | 23.41 Million |
| 85 |
Selvita S.A.
WAR:SLV |
$176.81 Million | zł642.44 Million | Poland | zł35.00 | +0.43% | +0.00% | 1.43 Million |
| 86 |
Devyser Diagnostics AB
ST:DVYSR |
$168.47 Million | Skr1.57 Billion | Sweden | Skr94.00 | -0.95% | +6.33% | 1.37 Million |
| 87 |
Burning Rock Biotech Ltd
NASDAQ:BNR |
$154.44 Million | $154.44 Million | USA | $17.10 | +0.56% | -16.97% | 738.12K |
| 88 |
JOONGANG DNM Co.Ltd
KQ:051980 |
$144.40 Million | ₩213.08 Billion | Korea | ₩1922.00 | -3.71% | -13.81% | 175.99 Million |
| 89 |
Prodia Widyahusada Tbk PT
JK:PRDA |
$139.53 Million | Rp2.38 Trillion | Indonesia | Rp2540.00 | +0.00% | +1.60% | 13.69 Million |
| 90 |
Access Bio Inc
KQ:950130 |
$125.38 Million | ₩185.01 Billion | Korea | ₩5260.00 | -1.31% | -0.94% | 3.72 Million |
| 91 |
Bionet
TWO:1784 |
$119.66 Million | NT$3.80 Billion | Taiwan | NT$75.50 | -0.26% | -3.82% | 4.40 Million |
| 92 |
MDxHealth SA ADR
NASDAQ:MDXH |
$111.46 Million | $111.46 Million | USA | $2.17 | -4.82% | -6.06% | 5.64 Million |
| 93 |
Scope Fluidics SA
WAR:SCP |
$103.68 Million | zł376.72 Million | Poland | zł138.20 | -0.58% | -2.26% | 35.96K |
| 94 |
BioPorto
CO:BIOPOR |
$96.05 Million | Dkr613.92 Million | Denmark | Dkr1.24 | +9.73% | +32.76% | 14.52 Million |
| 95 |
Fonar Corporation
NASDAQ:FONR |
$92.74 Million | $92.74 Million | USA | $18.93 | +0.00% | +0.53% | 1.12 Million |
| 96 |
Cytogen Inc
KQ:217330 |
$92.24 Million | ₩136.11 Billion | Korea | ₩5900.00 | +2.97% | +25.27% | 8.77 Million |
| 97 |
OncoCyte Corp
NASDAQ:OCX |
$90.37 Million | $90.37 Million | USA | $3.16 | -1.25% | +14.70% | 2.36 Million |
| 98 |
SCOPE FLUIDICS SA ZY-10
F:S84 |
$89.23 Million | €76.33 Million | Germany | €28.00 | +0.90% | -1.93% | 6.00 |
| 99 |
Centro de Imagem Diagnósticos S.A
SA:AALR3 |
$88.77 Million | R$452.40 Million | Brazil | R$2.97 | +6.07% | -2.94% | 1.73 Million |
| 100 |
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX |
$86.66 Million | $86.66 Million | USA | $4.18 | +4.24% | +18.75% | 9.82 Million |
| 101 |
Eurofins-Cerep SA
PA:ALECR |
$79.70 Million | €68.17 Million | France | €15900.00 | +0.63% | +0.63% | 14.00 |
| 102 |
Biodesix Inc
NASDAQ:BDSX |
$79.44 Million | $79.44 Million | USA | $11.08 | +0.91% | +11.24% | 1.33 Million |
| 103 |
Exagen Inc
NASDAQ:XGN |
$69.35 Million | $69.35 Million | USA | $3.06 | +5.52% | +14.18% | 4.76 Million |
| 104 |
DIVA Laboratories Ltd
TWO:4153 |
$56.56 Million | NT$1.80 Billion | Taiwan | NT$30.60 | +0.16% | -5.26% | 1.16 Million |
| 105 |
Pangaea Oncology S.A.
MC:PANG |
$56.33 Million | €48.18 Million | Spain | €1.64 | +0.00% | -4.65% | 57.17K |
| 106 |
Optipharm.CO.LTD
KQ:153710 |
$51.60 Million | ₩76.14 Billion | Korea | ₩5190.00 | -0.95% | -4.77% | 675.64K |
| 107 |
P&K Skin Research Center Co. Ltd
KQ:347740 |
$48.83 Million | ₩72.06 Billion | Korea | ₩2495.00 | -1.77% | +2.25% | 2.74 Million |
| 108 |
Cryosite Ltd
AU:CTE |
$39.72 Million | AU$56.13 Million | Australia | AU$1.15 | +0.00% | +9.52% | 64.44K |
| 109 |
Genoray Co. Ltd
KQ:122310 |
$38.45 Million | ₩56.74 Billion | Korea | ₩4620.00 | -2.63% | +0.22% | 1.88 Million |
| 110 |
Microba Life Sciences Ltd
AU:MAP |
$32.75 Million | AU$46.28 Million | Australia | AU$0.08 | +8.57% | +10.14% | 8.97 Million |
| 111 |
RHYTHM Biosciences Ltd
AU:RHY |
$32.49 Million | AU$45.92 Million | Australia | AU$0.14 | +3.70% | -15.15% | 14.25 Million |
| 112 |
Inoviq Ltd
AU:IIQ |
$32.37 Million | AU$45.75 Million | Australia | AU$0.33 | +0.00% | -4.41% | 1.88 Million |
| 113 |
Precipio Inc
NASDAQ:PRPO |
$31.61 Million | $31.61 Million | USA | $30.94 | +0.13% | +14.47% | 857.84K |
| 114 |
INOVIQ LTD.
F:EGQ0 |
$29.30 Million | €25.06 Million | Germany | €0.18 | -1.66% | -1.66% | 202.00 |
| 115 |
GeneMatrix Inc
KQ:109820 |
$27.26 Million | ₩40.23 Billion | Korea | ₩2015.00 | -2.42% | -5.40% | 6.86 Million |
| 116 |
Biocartis Group NV
BR:BCART |
$27.24 Million | €23.30 Million | Belgium | €0.29 | +0.00% | +0.00% | 0.00 |
| 117 |
Gencurix Inc
KQ:229000 |
$25.56 Million | ₩37.72 Billion | Korea | ₩2340.00 | -1.68% | +2.18% | 14.71 Million |
| 118 |
Bcal Diagnostics Ltd
AU:BDX |
$21.65 Million | AU$30.60 Million | Australia | AU$0.08 | +0.00% | -2.35% | 2.30 Million |
| 119 |
INIFY LABORATORIES AB
F:WY60 |
$20.83 Million | €17.82 Million | Germany | €0.26 | -0.76% | +0.77% | 0.00 |
| 120 |
Diagnos Laboratorium Utama PT Tbk
JK:DGNS |
$19.48 Million | Rp332.50 Billion | Indonesia | Rp266.00 | -4.32% | -5.00% | 30.38 Million |
| 121 |
NanoRepro AG
XETRA:NN6 |
$18.79 Million | €16.08 Million | Germany | €1.52 | -0.98% | -1.62% | 184.33K |
| 122 |
SenzaGen AB
ST:SENZA |
$17.21 Million | Skr159.91 Million | Sweden | Skr5.42 | -0.73% | +0.37% | 544.57K |
| 123 |
Enzo Biochem Inc
NYSE:ENZ |
$16.44 Million | $16.44 Million | USA | $0.54 | -0.02% | -8.65% | 1.34 Million |
| 124 |
Immunovia publ AB
ST:IMMNOV |
$14.70 Million | Skr136.55 Million | Sweden | Skr0.20 | -5.58% | +1.50% | 150.59 Million |
| 125 |
Genetic Signatures Ltd
AU:GSS |
$14.14 Million | AU$19.99 Million | Australia | AU$0.09 | +7.32% | -41.33% | 32.42 Million |
| 126 |
Biomaxima
WAR:BMX |
$13.55 Million | zł49.23 Million | Poland | zł11.74 | +0.69% | +1.56% | 59.12K |
| 127 |
AroCell AB
ST:AROC |
$13.39 Million | Skr124.39 Million | Sweden | Skr0.54 | +1.12% | +4.25% | 5.23 Million |
| 128 |
Predilife
PA:ALPRE |
$12.11 Million | €10.36 Million | France | €3.00 | -1.32% | -3.23% | 14.63K |
| 129 |
Inotiv Inc
NASDAQ:NOTV |
$10.66 Million | $10.66 Million | USA | $0.31 | +6.86% | +4.73% | 22.54 Million |
| 130 |
XWELL Inc.
NASDAQ:XWEL |
$10.15 Million | $10.15 Million | USA | $1.28 | +8.47% | +12.28% | 4.43 Million |
| 131 |
Check-Cap Ltd
F:7CC |
$9.91 Million | €8.48 Million | Germany | €1.19 | -1.65% | -11.85% | 2.11K |
| 132 |
IZOTROPIC CORP.
F:1R3 |
$9.91 Million | €8.47 Million | Germany | €0.18 | +0.00% | +15.58% | 4.00K |
| 133 |
bioAffinity Technologies, Inc.
NASDAQ:BIAF |
$9.85 Million | $9.85 Million | USA | $2.19 | -11.87% | -4.78% | 25.33 Million |
| 134 |
Check Cap Ltd
NASDAQ:CHEK |
$9.42 Million | $9.42 Million | USA | $139.00 | +0.72% | -2.80% | 22.52 Million |
| 135 |
NSN Co. Ltd
KQ:031860 |
$8.50 Million | ₩12.54 Billion | Korea | ₩693.00 | +17.26% | +15.69% | 50.75 Million |
| 136 |
GENINCODE PLC LS -01
F:9PL |
$8.48 Million | €7.25 Million | Germany | €0.01 | +0.00% | -4.76% | 400.00 |
| 137 |
Malaysian Genomics Resource
KLSE:0155 |
$7.96 Million | RM31.70 Million | Malaysia | RM0.21 | +5.00% | +5.00% | 5.45 Million |
| 138 |
Advanced Biomed Inc. Common Stock
NASDAQ:ADVB |
$7.19 Million | $7.19 Million | USA | $5.27 | -1.50% | -18.55% | 17.29 Million |
| 139 |
Imagion Biosystems Ltd
AU:IBX |
$5.90 Million | AU$8.34 Million | Australia | AU$0.02 | +21.43% | -5.56% | 45.22 Million |
| 140 |
ENDRA Life Sciences Inc
NASDAQ:NDRA |
$5.82 Million | $5.82 Million | USA | $4.95 | +1.64% | -1.00% | 460.89K |
| 141 |
CHINA HEALTH GRP HD-10
F:VNL1 |
$5.82 Million | €4.98 Million | Germany | €0.01 | +0.00% | +0.00% | 80.00K |
| 142 |
Mainz Biomed N.V.
NASDAQ:QUCY |
$5.14 Million | $5.14 Million | USA | $0.41 | -3.73% | -19.47% | 12.54 Million |
| 143 |
Avricore Health Inc
V:AVCR |
$5.13 Million | CA$7.09 Million | Canada | CA$0.07 | +7.69% | +16.67% | 964.26K |
| 144 |
Prostatype Genomics AB
ST:PROGEN |
$4.83 Million | Skr44.87 Million | Sweden | Skr0.76 | -5.72% | +1.07% | 2.63 Million |
| 145 |
Leveljump Healthcare Corp
V:JUMP |
$4.19 Million | CA$5.79 Million | Canada | CA$0.06 | +0.00% | -14.29% | 312.83K |
| 146 |
Mainz Biomed BV
NASDAQ:MYNZ |
$4.11 Million | $4.11 Million | USA | $0.76 | -10.15% | -16.66% | 18.17 Million |
| 147 |
Genetic Technologies Ltd
AU:GTG |
$4.01 Million | AU$5.67 Million | Australia | AU$0.04 | +0.00% | +0.00% | 0.00 |
| 148 |
Applied DNA Sciences Inc
NASDAQ:APDN |
$3.99 Million | $3.99 Million | USA | $3.09 | +3.00% | +24.10% | 1.14 Million |
| 149 |
Euroespes S.A.
MC:EEP |
$3.95 Million | €3.38 Million | Spain | €0.34 | +0.00% | +0.00% | 0.00 |
| 150 |
GENETIC ANALYSIS NK -60
F:8V8 |
$3.92 Million | €3.36 Million | Germany | €0.08 | +2.46% | +90.36% | 29.50K |
Track real-time market capitalization of largest public companies in the Diagnostics & Research industry. Compare marketcap, analyze stock performance, and discover leading diagnostics & research corporations. View all industries